Feed-forward stimulation of CAMK2 by the oncogenic pseudokinase PEAK1 generates a therapeutically "actionable" signalling axis in triple negative breast cancer.
Yang X, Ma X, Zhao T, Croucher DR, Nguyen EV, Clark KC, Hu C, Latham SL, Bayly-Jones C, Nguyen VCB, Budnar S, Shin S, Nguyen LK, Cotton TR, Chueh AC, Sian TCLK, Stratton MM, Ellisdon AM, Daly RJ.
Yang X, et al. Among authors: clark kc.
bioRxiv [Preprint]. 2024 Nov 22:2024.02.14.580406. doi: 10.1101/2024.02.14.580406.
bioRxiv. 2024.
PMID: 38405732
Free PMC article.
Preprint.